Learn more about investing in Xias Bio

Our team will get back to you soon to follow up on your inquiry.
Opt-In Checkbox
We don’t spam. Our Privacy Policy and Cookie Policy apply. The site is protected by reCAPTCHA.
Xias Bio
Replacing Animal Proteins
Founded
2020
Employees*
2-10
Funding to Date*
$5,186,500
Website
www.xiasbio.com
* Data source: Crunchbase
David Harvey, PhD, Co-Founder and Managing Director, Xias Bio Limited
“We design and supply high-performance, multi-functional proteins that address pain points within many different bioeconomic verticals. We aim to replace all animal proteins in use today.”
Using a 4,000 L fermenter—tiny in comparison to the 250,000 L tanks used widely in the personal care industry—Xias can produce 20 kg of protein. That’s enough for 1 million units of a typical skincare product.

Xias Bio is a biotechnology company focused on developing sustainable, animal-free protein alternatives with excellent product-market fit. The company engineers high-performance recombinant proteins that supersede animal-derived proteins such as collagen, keratin, and elastin. Using its proprietary LiteProtein™ platform, Xias Bio creates multifunctional proteins and peptide complexes that combine the functions of several conventional proteins into a single raw ingredient. These products are produced through fermentation, making them scalable, consistent, and environmentally friendly.

Xias Bio’s technology aims to reduce the environmental and ethical impacts associated with legacy sources while offering manufacturers functional, cost-effective ingredients. The company’s initial commercial focus is on cosmetics and personal care, with plans to expand into other sectors their customers operate including biotechnology, agriculture, and potentially pharmaceuticals. Rather than selling directly to consumers, Xias Bio primarily licenses its protein designs to ingredient manufacturers and industry partners.